97 related articles for article (PubMed ID: 10088455)
1. [Yersinia pseudotuberculosis infection].
Takeda N
Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):496-9. PubMed ID: 10088455
[No Abstract] [Full Text] [Related]
2. Characterization of a superantigen produced by Yersinia pseudotuberculosis.
Abe J; Takeda T
Prep Biochem Biotechnol; 1997; 27(2-3):173-208. PubMed ID: 9292925
[No Abstract] [Full Text] [Related]
3. [Yersinia pseudotuberculosis toxins].
Timchenko NF
Zh Mikrobiol Epidemiol Immunobiol; 2006; (6):83-9. PubMed ID: 17163146
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic role of a superantigen in Yersinia pseudotuberculosis infection.
Abe J; Kano H; Nogami H; Matsumoto S; Baba K; Saito H; Kohsaka T
Adv Exp Med Biol; 2003; 529():459-61. PubMed ID: 12756809
[No Abstract] [Full Text] [Related]
5. A novel superantigenic exotoxin from Yersinia psuedotuberculosis and its position in the classification of the entire bacterial toxins.
Uchiyama T
Contrib Microbiol Immunol; 1995; 13():191-4. PubMed ID: 8833831
[No Abstract] [Full Text] [Related]
6. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
[TBL] [Abstract][Full Text] [Related]
7. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
Viboud GI; Mejía E; Bliska JB
Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
[TBL] [Abstract][Full Text] [Related]
8. Purification and gene cloning of a superantigen (YPM) produced by a patient strain of Yersinia pseudotuberculosis.
Takeda T; Yoshino K; Itoh Y; Abe J; Shimonishi Y; Kohsaka T
Contrib Microbiol Immunol; 1995; 13():331-3. PubMed ID: 8833866
[No Abstract] [Full Text] [Related]
9. Attenuation and preserved immunogenic potential of Yersinia pseudotuberculosis mutant strains evidenced in oral pig model.
Najdenski H; Golkocheva-Markova E; Kussovski V; Vesselinova A; Garbom S; Wolf-Watz H
Zoonoses Public Health; 2009 May; 56(4):157-68. PubMed ID: 18793276
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Kawasaki disease showing elevated antibody titres of Yersinia pseudotuberculosis.
Tahara M; Baba K; Waki K; Arakaki Y
Acta Paediatr; 2006 Dec; 95(12):1661-4. PubMed ID: 17129979
[TBL] [Abstract][Full Text] [Related]
11. Influence of Yersinia pseudotuberculosis outer proteins (Yops) on interleukin-12, tumor necrosis factor alpha and nitric oxide production by peritoneal macrophages.
Monnazzi LG; Carlos IZ; de Medeiros BM
Immunol Lett; 2004 Jun; 94(1-2):91-8. PubMed ID: 15234540
[TBL] [Abstract][Full Text] [Related]
12. Yersinia enterocolitica and Yersinia pseudotuberculosis.
Naktin J; Beavis KG
Clin Lab Med; 1999 Sep; 19(3):523-36, vi. PubMed ID: 10549424
[TBL] [Abstract][Full Text] [Related]
13. [Modern concepts on the relationship between the agents causing plague and pseudotuberculosis].
Kukleva LM; Protsenko OA; Kutyrev VV
Mol Gen Mikrobiol Virusol; 2002; (1):3-7. PubMed ID: 11904922
[TBL] [Abstract][Full Text] [Related]
14. [Yersinia enteritis].
Sakamoto M; Sagara H
Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):493-5. PubMed ID: 10088454
[No Abstract] [Full Text] [Related]
15. Defensive function of phagocytes in pseudotuberculosis.
Plekhova NG; Somova-Isachkova LM; Shubin FN
Adv Exp Med Biol; 2003; 529():161-4. PubMed ID: 12756750
[No Abstract] [Full Text] [Related]
16. [The new views to pseudotuberculosis pathology].
Somova LM; Plekhova NG; Drobot EI
Arkh Patol; 2012; 74(3):60-4. PubMed ID: 22937584
[TBL] [Abstract][Full Text] [Related]
17. [The pathogenicity factors of Yersinia pseudotuberculosis and the pathogenetic aspects of pseudotuberculosis].
Timchenko NF
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):25-9. PubMed ID: 9432840
[No Abstract] [Full Text] [Related]
18. Yersinia pseudotuberculosis infection in a suckler calf in the United Kingdom: a case report.
Foster AP; Otter A; Bolger VA
Vet J; 2008 Jan; 175(1):139-40. PubMed ID: 17329133
[TBL] [Abstract][Full Text] [Related]
19. LcrV synthesis is altered by DNA adenine methylase overproduction in Yersinia pseudotuberculosis and is required to confer immunity in vaccinated hosts.
Badie G; Heithoff DM; Mahan MJ
Infect Immun; 2004 Nov; 72(11):6707-10. PubMed ID: 15501808
[TBL] [Abstract][Full Text] [Related]
20. [The entry portals and routes of Yersinia pseudotuberculosis penetration into the warm-blooded organism].
Timchenko NF; Antonenko FF
Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):15-9. PubMed ID: 2075758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
